Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis, Rheumatoid × Eicosapentaenoic Acid × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Psoriasis 1 Osteoarthritis 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Vitamin D 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Saline Solution 1 Practice Guidelines as Topic 1 Phlebotomy 1 Nivolumab 1 Methods 1 Interviews as Topic 1 Holistic Health 1 Fish Oils 1 Fatty Acids, Omega-3 1 Etanercept 1 Eicosapentaenoic Acid 1 Educational Status 1 Early Intervention, Educational 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01351805 2025-12-03

VITAL

Brigham and Women's Hospital

Phase NA Completed

25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡